Expert Insights On Patient Recruitment
-
Transforming Clinical Trials For Women In 2024
2/7/2024
Change is long overdue, and it begins with a fundamental shift in how we design clinical trials, placing women's perspectives and needs at the core of planning and implementation.
-
3 Areas Where AI Could Revolutionize Patient Recruitment And Retention
2/6/2024
Explore three ways in which AI can make a positive impact on patient recruitment and retention, as identified by life sciences consultant Ross Jackson.
-
4 Things I'm Looking Forward To At SCOPE 2024
2/1/2024
The Summit for Clinical Ops Executives (SCOPE) begins Feb. 11. Discover four things Executive Editor Abby Proch is looking forward to at the annual event.
-
Why — And How — To Improve Adherence To Treatment In Clinical Trials
1/12/2024
In part two of this series, discover the benefits of adherence to treatment, as well as immediate ways to leverage current services, tools, and resources to improve patient adherence.
-
Understanding The Effects Of Non-Adherence To Treatment In Clinical Trials
1/11/2024
In part one of this series, discover the severity of the patient nonadherence in clinical trials and understand the conditions that contribute to nonadherence to treatment.
-
What Clinical Trial Experts Think Will Happen With AI In 2024
12/26/2023
In part one of this preview of clinical trials trends for 2024, experts discuss the applications of AI in clinical research.
-
New Calculator Could Help Trial Participants And Sponsors Determine Costs And Fair Compensation
12/14/2023
Try the industry’s first open access financial burden calculator to help patients, sponsors, and other stakeholders estimate the cost burden patients may face.
-
Developing A Diversity Action Plan That Actually Works
12/7/2023
A successful diversity action plan (DAP) requires contributions of multiple cross-functional teams who are collectively well resourced and financed. Consultant Devra Densmore explains.
-
How Planning For Failure Can Bring Patient Recruitment Success
12/4/2023
To recruit patients successfully, it's actually worthwhile to first seek failure. Here, patient recruitment specialist Ross Jackson contends it's good practice for highlighting (and removing) bad practices.
-
Rare Disease vs. Chronic Conditions: Recruitment And Engagement Strategies
12/1/2023
Rare disease and chronic conditions, when it comes to studying their interventions in clinical trials, have similarities as well as differences — from protocol feasibility to patient recruitment and retention tactics. Consider the rare disease portfolio at Alexion Pharmaceuticals and chronic conditions in the AstraZeneca portfolio.